Topic

Illinois

A collection of 412 issues

How to Get Defitelio (Defibrotide) Covered by Aetna CVS Health in Illinois: Complete Guide with Forms and Appeals

Answer Box: Getting Defitelio Covered by Aetna in Illinois Defitelio (defibrotide) requires prior authorization from Aetna CVS Health for severe hepatic veno-occlusive disease (VOD/SOS) with organ dysfunction post-HSCT. Submit PA through Aetna provider portal with complete transplant records, organ dysfunction evidence, and FDA indication match. If denied, file internal

How to Get Adynovate (Antihemophilic Factor, PEGylated) Covered by Humana in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Adynovate Covered by Humana in Illinois Adynovate requires prior authorization from Humana Clinical Pharmacy Review (HCPR) for all Medicare Advantage plans in Illinois. The fastest path to approval: (1) Submit PA request with Factor VIII level <5%, bleeding history documentation, and hemophilia A diagnosis confirmation, (2)

How to Get Xyrem (Sodium Oxybate) Covered by Humana in Illinois: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Xyrem Covered by Humana in Illinois Xyrem (sodium oxybate) requires prior authorization from Humana and mandatory REMS enrollment before coverage. In Illinois, you have 65 days to appeal denials, followed by external review through the Illinois Department of Insurance if needed. Fastest path to approval: 1. Complete

Requirements Checklist to Get Vimizim (elosulfase alfa) Covered by UnitedHealthcare in Illinois: Complete Prior Authorization Guide

Answer Box: Getting Vimizim Covered by UnitedHealthcare in Illinois UnitedHealthcare requires prior authorization for Vimizim (elosulfase alfa) through OptumRx. To get approval, you need: confirmed MPS IVA diagnosis with GALNS enzyme deficiency, specialist prescription, baseline functional assessments, and proper documentation. Submit via the UHC provider portal using the OptumRx General

How to Get Strimvelis Gene Therapy Covered by Blue Cross Blue Shield in Illinois: Complete Guide to International Treatment Authorization and Appeals

Answer Box: Getting Strimvelis Covered in Illinois Strimvelis gene therapy for ADA-SCID requires special authorization from Blue Cross Blue Shield of Illinois (BCBSIL) as an experimental/international treatment. Start by calling BCBSIL member services at 1-800-892-2803 to verify international coverage benefits and request experimental treatment exception forms. Submit comprehensive medical

How to Get Uptravi (Selexipag) Covered by Cigna in Illinois: Appeal Guide with Forms and Timelines

Answer Box: Getting Uptravi (Selexipag) Covered by Cigna in Illinois Cigna requires prior authorization for Uptravi (selexipag) for pulmonary arterial hypertension (PAH). Your doctor must submit clinical documentation proving WHO Group 1 PAH diagnosis with functional class II-III symptoms and prior therapy trials. If denied, you have 180 days for

How to Get Trikafta (Elexacaftor/Tezacaftor/Ivacaftor) Covered by Aetna CVS Health in Illinois: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Trikafta Covered by Aetna CVS Health in Illinois Aetna CVS Health requires prior authorization for Trikafta (elexacaftor/tezacaftor/ivacaftor) with specific genetic and clinical documentation. You'll need CFTR genotype confirmation, baseline liver tests, and CF specialist consultation. Submit through the Aetna provider portal or call

Do You Qualify for Tremfya (Guselkumab) Coverage by UnitedHealthcare in Illinois? Decision Tree & Next Steps

Answer Box: Quick Qualification Check Most Illinois patients qualify for Tremfya (guselkumab) coverage through UnitedHealthcare if they have moderate-to-severe plaque psoriasis (PASI ≥10), psoriatic arthritis, or inflammatory bowel disease AND have failed required step therapy (typically TNF inhibitors like Humira plus other agents). Fastest path: Have your dermatologist or GI

How to Get Vitrakvi (Larotrectinib) Covered by Aetna CVS Health in Illinois: PA Forms, Appeal Scripts & Timeline Guide

Quick Answer: Aetna CVS Health requires prior authorization for Vitrakvi (larotrectinib) with documented NTRK gene fusion testing and evidence of metastatic/unresectable disease. Submit PA via CVS Specialty at 1-888-267-3277 with molecular pathology report, oncologist notes, and prior therapy documentation. If denied, appeal within 180 days using medical necessity letter

How to Get Hetlioz LQ (tasimelteon oral suspension) Covered by Cigna in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Cigna requires prior authorization for Hetlioz LQ (tasimelteon oral suspension) for Smith-Magenis syndrome in children 3-15 years old. Submit PA through Express Scripts/Accredo with genetic SMS confirmation, sleep specialist evaluation, and documented failures of ramelteon plus one alternative. Appeals follow Illinois's strong patient protection laws